Related references
Note: Only part of the references are listed.Circ_0037078 promotes trophoblast cell proliferation, migration, invasion and angiogenesis by miR-576-5p/IL1RAP axis
Hong Zou et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2022)
Therapeutic potential of CAR T cell in malignancies: A scoping review
Ali Zarezadeh Mehrabadi et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Overview of the pre-clinical and clinical studies about the use of CAR-T cell therapy of cancer combined with oncolytic viruses
Ali Zarezadeh Mehrabadi et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2022)
Circ_0007611 stimulates IL-1 receptor accessory protein to inhibit trophoblast cell proliferation and induce cell apoptosis
Haiyan Xing et al.
BIOLOGY OF REPRODUCTION (2022)
The roles of interleukin-1 receptor accessory protein in certain inflammatory conditions
Ali Zarezadeh Mehrabadi et al.
IMMUNOLOGY (2022)
Systematic molecular analysis of the human secretome and membrane proteome in gastrointestinal adenocarcinomas
Adeel Ur Rehman et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2022)
The interleukin-1 axis and the tumor immune microenvironment in pancreatic ductal adenocarcinoma
Kelly M. Herremans et al.
NEOPLASIA (2022)
Interaction Analysis of Adenovirus L5 Protein With Pancreatic Cancer Cell Surface Receptor to Analyze Its Affinity for Oncolytic Virus Therapy
Maryum Nisar et al.
FRONTIERS IN ONCOLOGY (2022)
Repositioning canakinumab for non-small cell lung cancer-important lessons for drug repurposing in oncology
Mark P. Lythgoe et al.
BRITISH JOURNAL OF CANCER (2022)
Targeting inflammation in lower-risk MDS
Jesus D. Gonzalez-Lugo et al.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2022)
Phase 1/2a trial of nadunolimab, a first-in-class fully humanized monoclonal antibody against IL1RAP, in combination with gemcitabine and nab-paclitaxel (GN) in patients with pancreatic adenocarcinoma (PDAC).
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Safety, tolerability, and preliminary efficacy of nadunolimab, a first-in-class monoclonal antibody against IL1RAP, in combination with pembrolizumab in subjects with solid tumors.
Shekeab Jauhari et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Phase 1/2a trial of nadunolimab, a first-in-class fully humanized monoclonal antibody against IL1RAP, in combination with cisplatin and gemcitabine (CG) in patients with non-small cell lung cancer (NSCLC).
Astrid Paulus et al.
JOURNAL OF CLINICAL ONCOLOGY (2022)
Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leukemia
Rim Trad et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
CircHIPK3 sponges miR-558 to suppress heparanase expression in bladder cancer cells
Yawei Li et al.
EMBO REPORTS (2022)
Overcoming target epitope masking resistance that can occur on low-antigen-expresser AML blasts after IL-1RAP chimeric antigen receptor T cell therapy using the inducible caspase 9 suicide gene safety switch
Walid Warda et al.
CANCER GENE THERAPY (2021)
miR-576-5p promotes epithelial-to-mesenchymal transition in colorectal cancer by targeting the Wnt5a-mediated Wnt/β-catenin signaling pathway
Jialin Luo et al.
MOLECULAR MEDICINE REPORTS (2021)
The revisited role of interleukin-1 alpha and beta in autoimmune and inflammatory disorders and in comorbidities
Paola Galozzi et al.
AUTOIMMUNITY REVIEWS (2021)
IL1RAP Pulls a Double Shift in the Cysteine Factory
Sang Jun Yoon et al.
CANCER DISCOVERY (2021)
Structural Evolution of TIR-Domain Signalosomes
Surekha Nimma et al.
FRONTIERS IN IMMUNOLOGY (2021)
The ever-increasing importance of cancer as a leading cause of premature death worldwide
Freddie Bray et al.
CANCER (2021)
Proteomic Screens for Suppressors of Anoikis Identify IL1RAP as a Promising Surface Target in Ewing Sarcoma
Hai-Feng Zhang et al.
CANCER DISCOVERY (2021)
The IL1-IL1RAP axis plays an important role in the inflammatory leukemic niche that favors acute myeloid leukemia proliferation over normal hematopoiesis
Bauke De Boer et al.
HAEMATOLOGICA (2021)
The Potential Role of IL1RAP on Tumor Microenvironment-Related Inflammatory Factors in Stomach Adenocarcinoma
Qing Lv et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2021)
Circ0001320 inhibits lung cancer cell growth and invasion by regulating TNFAIP1 and TPM1 expression through sponging miR-558
Yong Mao et al.
HUMAN CELL (2021)
Associations of IL6 rs1800795, BLK rs13277113, TIMP3 rs9621532, IL1RL1 rs1041973 and IL1RAP rs4624606 single gene polymorphisms with laryngeal squamous cell carcinoma
Agne Pasvenskaite et al.
GENE (2020)
IL1RAP regulated by PRPRD promotes gliomas progression via inducing neuronal synapse development and neuron differentiation in vitro
Feng Li et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
Alternative Pathways of IL-1 Activation, and Its Role in Health and Disease
Katerina Pyrillou et al.
FRONTIERS IN IMMUNOLOGY (2020)
circMAN1A2 could serve as a novel serum biomarker for malignant tumors
Chun-Mei Fan et al.
CANCER SCIENCE (2019)
Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity
Alberto Mantovani et al.
IMMUNITY (2019)
Consequences of EMT-Driven Changes in the Immune Microenvironment of Breast Cancer and Therapeutic Response of Cancer Cells
Snahlata Singh et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Molecular prognosticators in clinically and pathologically distinct cohorts of head and neck squamous cell carcinoma-A meta-analysis approach
Ram Bhupal Reddy et al.
PLOS ONE (2019)
IL-1 Family Members in Cancer; Two Sides to Every Story
Kevin J. Baker et al.
FRONTIERS IN IMMUNOLOGY (2019)
Structural Basis of IL-1 Family Cytokine Signaling
James K. Fields et al.
FRONTIERS IN IMMUNOLOGY (2019)
Linc-PINT acted as a tumor suppressor by sponging miR-543 and miR-576-5p in esophageal cancer
Lingmin Zhang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
CML Hematopoietic Stem Cells Expressing IL1RAP Can Be Targeted by Chimeric Antigen Receptor-Engineered T Cells
Walid Warda et al.
CANCER RESEARCH (2019)
Investigation of cytotoxic, genotoxic, and apoptotic effects of curcumin on glioma cells
Mehmet Hakan Seyithanoglu et al.
CELLULAR AND MOLECULAR BIOLOGY (2019)
The role of interleukin-1 in general pathology
Naoe Kaneko et al.
INFLAMMATION AND REGENERATION (2019)
IL-1 and IL-1 regulatory pathways in cancer progression and therapy
Alberto Mantovani et al.
IMMUNOLOGICAL REVIEWS (2018)
The role of the interleukin-1 family in trained immunity
Simone J. C. F. M. Moorlag et al.
IMMUNOLOGICAL REVIEWS (2018)
The family of the interleukin-1 receptors
Diana Boraschi et al.
IMMUNOLOGICAL REVIEWS (2018)
CAR T-cell Therapy: A New Era in Cancer Immunotherapy
Miliotou N. Androulla et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2018)
IL1RAP potentiates multiple oncogenic signaling pathways in AML
Kelly Mitchell et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
SRSF10-mediated IL1RAP alternative splicing regulates cervical cancer oncogenesis via mIL1RAP-NF-κB-CD47 axis
Fei Liu et al.
ONCOGENE (2018)
Synthetic human monoclonal antibody targets hIL1 receptor accessory protein chain with therapeutic potential in triple-negative breast cancer
Pengfei Zheng et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Interleukin-1 Beta-A Friend or Foe in Malignancies?
Rebekka Bent et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
miR-193b and miR-30c-1* inhibit, whereas miR-576-5p enhances melanoma cell invasion in vitro
Theresa Kordaß et al.
Oncotarget (2018)
The Role of Type 1 Conventional Dendritic Cells in Cancer Immunity
Jan P. Boettcher et al.
TRENDS IN CANCER (2018)
Research of differential expression of sIL1RAP in low-grade gliomas between children and adults
Jintao He et al.
BRAIN TUMOR PATHOLOGY (2018)
The Role of Interleukin-1 in the Pathogenesis of Cancer and its Potential as a Therapeutic Target in Clinical Practice
Adi Litmanovich et al.
ONCOLOGY AND THERAPY (2018)
From inflammation to cancer
A. Korniluk et al.
IRISH JOURNAL OF MEDICAL SCIENCE (2017)
The implication of FLT3 amplification for FLT targeted therapeutics in solid tumors
Sung Hee Lim et al.
ONCOTARGET (2017)
Post-Translational Modifications of the TAK1-TAB Complex
Yusuke Hirata et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy
Erhao Zhang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
Paul M. Ridker et al.
LANCET (2017)
Roles of the TRAF6 and Pellino E3 ligases in MyD88 and RANKL signaling
Sam Strickson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
C-Kit receptor and tryptase expressing mast cells correlate with angiogenesis in breast cancer patients
Ilaria Marech et al.
Oncotarget (2017)
Molecular Pathways: Targeting Protein Tyrosine Phosphatases in Cancer
Lakshmi Reddy Bollu et al.
CLINICAL CANCER RESEARCH (2017)
Emerging Biological Principles of Metastasis
Arthur W. Lambert et al.
CELL (2017)
IL1RAP expression as a measure of leukemic stem cell burden at diagnosis of chronic myeloid leukemia predicts therapy outcome
N. Landberg et al.
LEUKEMIA (2016)
Protein tyrosine phosphatases receptor type D is a potential tumour suppressor gene inactivated by deoxyribonucleic acid methylation in paediatric acute myeloid leukaemia
Lei Song et al.
ACTA PAEDIATRICA (2016)
Interleukins 1 and 6 as main mediators of inflammation and cancer
O. S. Dmitrieva et al.
BIOCHEMISTRY-MOSCOW (2016)
IL1RAP antibodies block IL-1-induced expansion of candidate CML stem cells and mediate cell killing in xenograft models
Helena Agerstam et al.
BLOOD (2016)
Cell of origin of glioma: biological and clinical implications
Sheila R. Alcantara Llaguno et al.
BRITISH JOURNAL OF CANCER (2016)
Structural and Functional Attributes of the Interleukin-36 Receptor
Guanghui Yi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
miRNA-558 promotes gastric cancer progression through attenuating Smad4-mediated repression of heparanase expression
Liduan Zheng et al.
CELL DEATH & DISEASE (2016)
Interleukin-1 blockade overcomes erlotinib resistance in head and neck squamous cell carcinoma
Aditya Stanam et al.
ONCOTARGET (2016)
IL-1 drives breast cancer growth and bone metastasis in vivo
Ingunn Holen et al.
ONCOTARGET (2016)
The N-terminal loop of IRAK-4 death domain regulates ordered assembly of the Myddosome signalling scaffold
Anthony C. G. Dossang et al.
SCIENTIFIC REPORTS (2016)
Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer
David S. Hong et al.
INVESTIGATIONAL NEW DRUGS (2015)
A phase III study of xilonix in refractory colorectal cancer patients with weight loss.
George A. Fisher
JOURNAL OF CLINICAL ONCOLOGY (2015)
Addressing the challenges of pancreatic cancer: Future directions for improving outcomes
Manuel Hidalgo et al.
PANCREATOLOGY (2015)
Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia
Helena Agerstam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Mechanisms of splicing-dependent trans-synaptic adhesion by PTPδ-IL1RAPL1/IL-1RAcP for synaptic differentiation
Atsushi Yamagata et al.
NATURE COMMUNICATIONS (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia
Harald Herrmann et al.
BLOOD (2014)
The immune system and inflammation in breast cancer
Xinguo Jiang et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study
David S. Hong et al.
LANCET ONCOLOGY (2014)
Structural biology of the IL-1 superfamily: Key cytokines in the regulation of immune and inflammatory responses
Brian Krumm et al.
PROTEIN SCIENCE (2014)
Epidemiologic Trends in Head and Neck Cancer and Aids in Diagnosis
Nadarajah Vigneswaran et al.
ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA (2014)
C-Kit Expression, Angiogenesis, and Grading in Canine Mast Cell Tumour: A Unique Model to Study C-Kit Driven Human Malignancies
Rosa Patruno et al.
BIOMED RESEARCH INTERNATIONAL (2014)
The inducible caspase-9 suicide gene system as a safety switch to limit on-target, off-tumor toxicities of chimeric antigen receptor T cells
Tessa Gargett et al.
FRONTIERS IN PHARMACOLOGY (2014)
The role IL-1 in tumor-mediated angiogenesis
Elena Voronov et al.
FRONTIERS IN PHYSIOLOGY (2014)
OPINION Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression
Cassandra L. Buchheit et al.
NATURE REVIEWS CANCER (2014)
Harnessing the Power of the Immune System to Target Cancer
Gregory Lizee et al.
ANNUAL REVIEW OF MEDICINE, VOL 64 (2013)
ERBB4 confers metastatic capacity in Ewing sarcoma
Ariadna Mendoza-Naranjo et al.
EMBO MOLECULAR MEDICINE (2013)
The complexity of NF-κB signaling in inflammation and cancer
Bastian Hoesel et al.
MOLECULAR CANCER (2013)
Interleukin-1 Receptor Accessory Protein Organizes Neuronal Synaptogenesis as a Cell Adhesion Molecule
Tomoyuki Yoshida et al.
JOURNAL OF NEUROSCIENCE (2012)
STEM CELL FACTOR RECEPTOR/c-KIT: FROM BASIC SCIENCE TO CLINICAL IMPLICATIONS
Johan Lennartsson et al.
PHYSIOLOGICAL REVIEWS (2012)
IL-1α and IL-1β Recruit Different Myeloid Cells and Promote Different Stages of Sterile Inflammation
Peleg Rider et al.
JOURNAL OF IMMUNOLOGY (2011)
Insights into the stem cells of chronic myeloid leukemia
I. Sloma et al.
LEUKEMIA (2010)
IL-1 pathways in inflammation and human diseases
Cem Gabay et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein
Marcus Jaras et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials
C. Salliot et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
A Central Nervous System-Restricted Isoform of the Interleukin-1 Receptor Accessory Protein Modulates Neuronal Responses to Interleukin-1
Dirk E. Smith et al.
IMMUNITY (2009)
An Oligomeric Signaling Platform Formed by the Toll-like Receptor Signal Transducers MyD88 and IRAK-4
Precious G. Motshwene et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
G. Solinas et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Identification of the phosphorylation sites on the E3 ubiquitin ligase Pellino that are critical for activation by IRAK1 and IRAK4
Hilary Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The IRAK-catalysed activation of the E3 ligase function of Pellino isoforms induces the Lys(63)-linked polyubiquitination of IRAK1
Alban Ordureau et al.
BIOCHEMICAL JOURNAL (2008)
A novel alternatively spliced interleukin-1 receptor accessory protein mIL-1RAcP687
Hsin-Lin Lu et al.
MOLECULAR IMMUNOLOGY (2008)
Human papillomavirus: E6 and E7 oncogenes
Gaele Boulet et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Detection of molecular targets on the surface of CD34+/CD38-stem cells in various myeloid malignancies
S Florian et al.
LEUKEMIA & LYMPHOMA (2006)
The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions
Ron N. Apte et al.
CANCER AND METASTASIS REVIEWS (2006)
TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo
JH Shim et al.
GENES & DEVELOPMENT (2005)
Essential function for the kinase TAK1 in innate and adaptive immune responses
S Sato et al.
NATURE IMMUNOLOGY (2005)
Clinical significance of FLT3 in leukemia
H Kiyoi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2005)
Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia
R Ren
NATURE REVIEWS CANCER (2005)
Gastric adenocarcinoma - Review and considerations for future directions
BJ Dicken et al.
ANNALS OF SURGERY (2005)
Sequential autophosphorylation steps in the interleukin-1 receptor-associated kinase-1 regulate its availability as an adapter in interleukin-1 signaling
C Kollewe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The role of FLT3 in haematopoietic malignancies
DL Stirewalt et al.
NATURE REVIEWS CANCER (2003)
Expression of alternatively spliced interleukin-1receptor accessory protein mRNAs is differentially regulated during inflammation and apoptosis
LE Jensen et al.
CELLULAR SIGNALLING (2003)
The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type IIIL-1 receptor to inhibit IL-1 action
DE Smith et al.
IMMUNITY (2003)
IRAK-4: A novel member of the IRAK family with the properties of an IRAK-kinase
SY Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5
F Hayashi et al.
NATURE (2001)
Role of TLR-8 in the activation of nuclear factor κB by oxidative stress in cardiac myocytes
S Frantz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
A Toll-like receptor recognizes bacterial DNA
H Hemmi et al.
NATURE (2000)
Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain
L Deng et al.
CELL (2000)
Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor
K Burns et al.
NATURE CELL BIOLOGY (2000)
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
EM El-Omar et al.
NATURE (2000)
Share Paper
